Browsing by Author Joshua, Douglas

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 21 to 40 of 54 < previous   next >
Issue DateTitleAuthor(s)Citation
2011The impact of mandatory fortification of flour with folic acid on the blood folate levels of an Australian populationGibson, John; Joshua, Douglas; Brown, Ross D.; Langshaw, M.; Uhr, Elaine J.; Central Clinical School: Medicine; Central Clinical School: MedicineThe impact of mandatory fortification of flour with folic acid on the blood folate levels of an Australian population, Medical Journal of Australia, vol.194, 2, 2011,pp 65-67
2017Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR studyJoshua, Douglas; Chng, W-J; et al, Various; Facon, Thierry; Goldschmidt, Hartmut; Hajek, Roman; Ludwig, Heinz; Moreau, Philippe; Niesvizky, R.; Palumbo, Antonio; Pour, Ludek; Central Clinical School: MedicineImpact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study, Leukemia, vol.31, 1, 2017,pp 115-122
2011Interferon-Alpha in the Treatment of Multiple MyelomaGibson, John; Joshua, Douglas; Khoo, Teh Liane; Vangsted, Annette Juul; Central Clinical School: Medicine; Central Clinical School: MedicineInterferon-Alpha in the Treatment of Multiple Myeloma, Current Drug Targets (online), vol.12, 3, 2011,pp 437-446
2014International Myeloma Working Group recommendations for global myeloma careJoshua, Douglas; Dimopoulos, Meletios Athanassios; et al, Various; Gracia Sanz, Ramon; Hou, Jian; Lentzsch, Suzanne; Ludwig, H; Miguel, Jesus San; Ming Chen, W; Palumbo, Antonio; Powles, Ray; Central Clinical School: MedicineInternational Myeloma Working Group recommendations for global myeloma care, Leukemia, vol.28, 5, 2014,pp 981-992
2016International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal ImpairmentJoshua, Douglas; Dimopoulos, Meletios A; Durie, Brian G M; et al, Various; Garderet, Laurent; Goldschmidt, Hartmut; Kastritis, Efstathios; Leung, Nelson; Ludwig, Heinz; Merlini, Giampaolo; Orlowski, Robert Z; Powles, Ray; Rajkumar, S Vincent; Richardson, Paul G; Sonneveld, Pieter; Vesole, David H.; Central Clinical School: MedicineInternational Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment, Journal of Clinical Oncology, vol.34, 13, 2016,pp 1544-1557
2013Leukaemias into the 21st century - part 2: the chronic leukaemiasBrown, Catherine; Gibson, John; Iland, Harry; Joshua, Douglas; Larsen, S; Science Faculty Admin; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; MedicineLeukaemias into the 21st century - part 2: the chronic leukaemias, Internal Medicine Journal, vol.43, 5, 2013,pp 484-494
2004Long-Term Follow Up Of Sequential Mobilisation And Autologous Transplantation With Cd34-Selected Cells In Multiple Myeloma: A Multimodality Approach.Brown, Richard; Gibson, John; Joshua, Douglas; Barrow, L; Dyson, P; Gower, G; Hahn, U; Horvath, Noemi; Mills, B; Norman, J; Rawling, T; Stephens, S; Stevens, J; To, L B; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: MedicineLong-Term Follow Up Of Sequential Mobilisation And Autologous Transplantation With Cd34-Selected Cells In Multiple Myeloma: A Multimodality Approach., Internal Medicine Journal, vol.34,(N/A),2004,pp 167-175
2013Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balanceBryant, Christian; Fromm, Phillip; Hart, Derek; Ho, Phoebe (Joy); Iland, Harry; Joshua, Douglas; Aklilu, Esther; Brown, Ross; Favaloro, James; Gibson, J; Nassif, N; Suen, Hayley; Woodland, N. B.; Yang, S; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: MedicineLong-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance, Blood Cancer Journal, vol.3, N/A, 2013,pp 1-7
2004Low-Grade Lymphoma: The Optimal Timing.Gibson, John; Ho, Phoebe (Joy); Joshua, Douglas; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: MedicineLow-Grade Lymphoma: The Optimal Timing., Transplantation Proceedings 2005, vol.36,(7),2004,pp 1995-1998
2016Management of relapsed multiple myeloma: recommendations of the International Myeloma Working GroupJoshua, Douglas; Caers, J; et al, Various; Gahrton, Gosta; Garderet, Laurent; Johnsen, H E; Laubach, Jacob P.; Leleu, Xavier; Mahindra, Anuj K; Sezer, Orhan; Voorhees, P; Central Clinical School: MedicineManagement of relapsed multiple myeloma: recommendations of the International Myeloma Working Group, Leukemia, vol.30, 5, 2016,pp 1005-1017
2016Management of relapsed multiple myeloma: recommendations of the International Myeloma Working GroupJoshua, Douglas; Caers, J; et al, Various; Gahrton, Gosta; Garderet, Laurent; Johnsen, H E; Laubach, Jacob P.; Leleu, Xavier; Mahindra, Anuj K; Sezer, Orhan; Voorhees, P; Central Clinical School: MedicineManagement of relapsed multiple myeloma: recommendations of the International Myeloma Working Group, Leukemia, vol.30, 5, 2016,pp 1005-1017
2012Multiple myelomaHsu, Danny; Joshua, Douglas; Wilkenfeld, Peter; Central Clinical School: Medicine; Central Clinical School: MedicineMultiple myeloma, BMJ (Online), vol.344, 7840, 2012,pp 1-3
2016Multiple myeloma causes clonal T-cell immunosenescence: Identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockadeBryant, Catherine; Gibson, John; Hart, Derek; Ho, Joy Phoebe; Joshua, Douglas; Weatherburn, Claire; Barbaro, P; Brown, Ross D.; Nassif, Najah T; Suen, Hayley; Woodland, N. B.; Yang, Shihong; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: MedicineMultiple myeloma causes clonal T-cell immunosenescence: Identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade, Leukemia, vol.30, 8, 2016,pp 1716-1724
2016Multiple myeloma causes clonal T-cell immunosenescence: Identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockadeBryant, Catherine; Gibson, John; Hart, Derek; Ho, Joy Phoebe; Joshua, Douglas; Weatherburn, Claire; Barbaro, P; Brown, Ross D.; Nassif, Najah T; Suen, Hayley; Woodland, N. B.; Yang, Shihong; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: MedicineMultiple myeloma causes clonal T-cell immunosenescence: Identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade, Leukemia, vol.30, 8, 2016,pp 1716-1724
2014Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myelomaHart, Derek; Joshua, Douglas; Brown, Ross; Favaloro, James; Fromm, Phillip D; Gibson, John; Ho, P J; Liyadipitiya, Tulita; Nassif, Najah; Suen, Hayley; Weatherburn, Claire; Woodland, N. B.; Yang, Shihong; Concord Clinical School: ANZAC Research Institute; Central Clinical School: MedicineMyeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma, Leukemia & Lymphoma, vol.55, 12, 2014,pp 2893-2900
2014Myeloma skews regulatory T and pro-inflammatory T helper 17 cell balance in favor of a suppressive stateFromm, Phillip; Hart, Derek; Ho, Joy Phoebe; Joshua, Douglas; Aklilu, Esther; Brown, Ross; Favaloro, James; Gibson, John; Khoo, Liane; Suen, Hayley; Yang, Shihong; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: MedicineMyeloma skews regulatory T and pro-inflammatory T helper 17 cell balance in favor of a suppressive state, Leukemia & Lymphoma, vol.55, 5, 2014,pp 1090-1098
2013Performance evaluation of the Abbott CELL-DYN Emerald for use as a bench-top analyzer in a research settingGuan, F.; Holst, Jeffrey; Joshua, Douglas; Khoo, Teh-Liane; Rasko, John; Orellana, D.; Xiros, N.; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Centenary InstitutePerformance evaluation of the Abbott CELL-DYN Emerald for use as a bench-top analyzer in a research setting, International Journal of Laboratory Hematology, vol.35, 4, 2013,pp 447-456
2015Phospho-flow detection of constitutive and cytokine-induced pSTAT3/5, pAKT and pERK expression highlights novel prognostic biomarkers for patients with multiple myelomaHart, Derek; Ho, Joy Phoebe; Joshua, Douglas; Brown, R. D.; Gibson, J; Suen, Hayley; Weatherburn, Claire; Yang, S; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: MedicinePhospho-flow detection of constitutive and cytokine-induced pSTAT3/5, pAKT and pERK expression highlights novel prognostic biomarkers for patients with multiple myeloma, Leukemia, vol.29, 2, 2015,pp 483-490
2010Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapyGurney, Howard; Joshua, Douglas; Kerridge, Ian; McLachlan, Andrew; Shaw, Peter; Trotman, Judith; Duffull, Stephen B.; Earl, John W; Hegarty, Gareth; Kwan, Yiu Lam; Nath, Christa E.; Presgrave, Peter; Tiley, Campbell; Zeng, Lihua; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Central Clinical School: Ctr for Values Ethics & Law in Med; Pharmacy; Children's Hospital Westmead: Paediatrics & Child Health; Concord Clinical School: MedicinePopulation pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy, British Journal of Clinical Pharmacology, vol.69, 5,pp 484-497
2003Prediction of high affinity class I-restricted multiple myeloma idiotype peptide epitopesBasten, Antony; Fazekas De St Groth, Barbara; Gibson, John; Ho, Phoebe (Joy); Joshua, Douglas; Sze, Daniel; Brown, Ross D.; Yang, Shihong; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; PharmacyPrediction of high affinity class I-restricted multiple myeloma idiotype peptide epitopes, Leukemia & lymphoma, vol.44,(9),2003,pp 1557-1568